Institut Paoli-calmettes
Clinical trials sponsored by Institut Paoli-calmettes, explained in plain language.
-
New hope for older AML patients: gentler transplant approach aims to boost survival with less toxicity
Disease control Not yet recruitingThis study tests a reduced-intensity chemotherapy combination (fludarabine and treosulfan) before a half-matched stem cell transplant in 77 older or frail adults with AML. The goal is to see if this gentler regimen can control the leukemia long-term while being safe enough for pa…
Phase: PHASE2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
New radiation technique aims to prevent dangerous blood drops in cervical cancer patients
Symptom relief Not yet recruitingThis study tests whether a new way of planning radiation—sparing the pelvic and lower spine bones—can lower the risk of severe blood-related side effects in women with advanced cervical cancer. About 72 participants will receive standard chemoradiotherapy, but half will have thei…
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Symptom relief
Last updated Jun 10, 2026 13:25 UTC
-
Gene test could tailor chemo for tough pancreatic cancers
Knowledge-focused Not yet recruitingThis study aims to see if using a genetic test (transcriptomic signature) to choose chemotherapy improves outcomes for people with borderline resectable pancreatic cancer. About 367 participants will receive standard chemotherapy, and researchers will track how long they live wit…
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 17, 2026 01:47 UTC